MDWD MediWound Ltd.
$12.07▲ +0.54%
Healthcare
Other
Volume 83.9K
Avg Volume (10D) 111.1K
Key Metrics & Fundamentals
Market Cap
$155.76M
P/E Ratio
–
Div Yield
0.00%
52W Range
11.80 - 19.70
% vs 50 MA
-7.66%
% vs 200 MA
-21.23%
RSI-14
40.2
MACD Histogram
-0.0300
Beta (1Y vs SPY)
0.70
Free Cash Flow
-$10.20M
Gross Rev
$3.09M
Gross Profit
$337,000
EBITDA
-$9.06M
COGS
$2.76M
Operating Exp
$9.80M
Operating Income
-$9.46M
EBIT
-$9.46M
Pretax Income
-$7.36M
Net Income
-$7.39M
EPS (Diluted)
-0.77
Price & Volume History
Loading chart…
Recent News

MediWound Awarded Additional $3.3 Million from U.S. Department of War to Advance Room-Temperature-Stable Formulation of NexoBrid®
GlobeNewswire · Sep 22, 2026 7:00 AM ET

Independent DSMB Recommends MediWound’s EscharEx® Phase III VALUE Study Continue Without Modification
GlobeNewswire · Sep 14, 2026 7:00 AM ET

MediWound to Present at the H.C. Wainwright 28th Annual Global Investment Conference
GlobeNewswire · Sep 2, 2026 7:00 AM ET

MediWound (MDWD) Q2 2026 Earnings Call Transcript
Motley Fool · Aug 20, 2026 8:42 AM ET
Oppenheimer Adjusts Price Target on MediWound to $30 From $32, Keeps Outperform Rating
MT Newswires · Aug 14, 2026 8:45 AM ET

MediWound Ltd. Q2 2026 Earnings Call Summary
Moby · Aug 14, 2026 8:30 AM ET
MediWound Ltd (MDWD) (Q2 2026) Earnings Call Highlights: Record NexoBrid Sales and EscharEx ...
GuruFocus.com · Aug 13, 2026 7:07 PM ET

MediWound Q2 Earnings Call Highlights
MarketBeat · Aug 13, 2026 2:04 PM ET

MediWound (MDWD) Reports Q2 Loss, Beats Revenue Estimates
Zacks · Aug 13, 2026 8:15 AM ET
MediWound: Q2 Earnings Snapshot
Associated Press · Aug 13, 2026 7:11 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See MDWD's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.